| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyBiologicalProcess | neuron development | HSPG2 RELN FN1 MAP1B MYCBP2 DISC1 CRTC1 ADGRV1 GPRIN1 WNK1 GBA2 WDR47 PRDM1 PTPRF CLU PLXNC1 MTOR PTPRZ1 RP1L1 RP1 GRIP2 CAMSAP1 PBX2 SMAD4 | 2.02e-07 | 1463 | 104 | 24 | GO:0048666 |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | SLAIN2 HSPG2 MAP1B WASHC3 GBA2 WDR47 CLU MTOR RP1 CAMSAP1 SMAD4 | 1.32e-05 | 438 | 104 | 11 | GO:1902903 |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization or depolymerization | 1.79e-05 | 108 | 104 | 6 | GO:0031110 | |
| GeneOntologyBiologicalProcess | regulation of microtubule cytoskeleton organization | 3.10e-05 | 176 | 104 | 7 | GO:0070507 | |
| GeneOntologyBiologicalProcess | negative regulation of microtubule depolymerization | 3.95e-05 | 38 | 104 | 4 | GO:0007026 | |
| GeneOntologyBiologicalProcess | glial cell migration | 5.27e-05 | 80 | 104 | 5 | GO:0008347 | |
| GeneOntologyBiologicalProcess | regulation of microtubule depolymerization | 5.89e-05 | 42 | 104 | 4 | GO:0031114 | |
| GeneOntologyBiologicalProcess | positive regulation of cell development | RELN FN1 MAP1B DISC1 ARID1A PTPRF PLXNC1 MTOR PTPRZ1 ARID2 CD40LG GRIP2 | 6.20e-05 | 614 | 104 | 12 | GO:0010720 |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 6.33e-05 | 197 | 104 | 7 | GO:1902904 | |
| GeneOntologyBiologicalProcess | protein-containing complex disassembly | 1.14e-04 | 291 | 104 | 8 | GO:0032984 | |
| GeneOntologyBiologicalProcess | regulation of cell development | RELN FN1 MAP1B DISC1 ARID1A PRDM1 FANCA PTPRF PLXNC1 MTOR PTPRZ1 ARID2 FAM210B CD40LG GRIP2 SMAD4 | 1.15e-04 | 1095 | 104 | 16 | GO:0060284 |
| GeneOntologyBiologicalProcess | negative regulation of microtubule polymerization or depolymerization | 1.27e-04 | 51 | 104 | 4 | GO:0031111 | |
| GeneOntologyBiologicalProcess | T cell differentiation | 1.36e-04 | 382 | 104 | 9 | GO:0030217 | |
| GeneOntologyBiologicalProcess | cellular response to Thyroglobulin triiodothyronine | 1.50e-04 | 4 | 104 | 2 | GO:1904017 | |
| GeneOntologyBiologicalProcess | eye development | 1.57e-04 | 480 | 104 | 10 | GO:0001654 | |
| GeneOntologyBiologicalProcess | regulation of cytoskeleton organization | SLAIN2 TPR MAP1B MYCBP2 WASHC3 GBA2 WDR47 MTOR RP1 CAMSAP1 SMAD4 | 1.63e-04 | 579 | 104 | 11 | GO:0051493 |
| GeneOntologyBiologicalProcess | visual system development | 1.65e-04 | 483 | 104 | 10 | GO:0150063 | |
| GeneOntologyBiologicalProcess | nucleosome disassembly | 1.79e-04 | 22 | 104 | 3 | GO:0006337 | |
| GeneOntologyBiologicalProcess | organelle assembly | TPR RELN RNF186 ODAD1 DISC1 DYNC2I1 WNK1 NCOR1 EIF4ENIF1 MTOR RP1L1 EIF5B RP1 LRBA DDX28 SMAD4 | 1.79e-04 | 1138 | 104 | 16 | GO:0070925 |
| GeneOntologyBiologicalProcess | sensory system development | 1.89e-04 | 491 | 104 | 10 | GO:0048880 | |
| GeneOntologyBiologicalProcess | positive regulation of cell projection organization | 1.98e-04 | 494 | 104 | 10 | GO:0031346 | |
| GeneOntologyBiologicalProcess | microtubule polymerization or depolymerization | 2.10e-04 | 168 | 104 | 6 | GO:0031109 | |
| GeneOntologyBiologicalProcess | neuron projection development | HSPG2 RELN FN1 MAP1B MYCBP2 DISC1 CRTC1 ADGRV1 GPRIN1 WDR47 PTPRF CLU PLXNC1 MTOR PTPRZ1 CAMSAP1 SMAD4 | 2.28e-04 | 1285 | 104 | 17 | GO:0031175 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | HSPG2 PDE3B FN1 SPN DISC1 ARID1A WNK1 PLXNC1 MTOR PTPRZ1 ARID2 BTNL2 CD40LG MUC4 | 2.29e-04 | 927 | 104 | 14 | GO:0030155 |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 2.31e-04 | 171 | 104 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | protein-DNA complex disassembly | 2.33e-04 | 24 | 104 | 3 | GO:0032986 | |
| GeneOntologyBiologicalProcess | T-helper 1 cell lineage commitment | 2.49e-04 | 5 | 104 | 2 | GO:0002296 | |
| GeneOntologyBiologicalProcess | cellular component disassembly | MAP1B ARID1A WNK1 WDR47 VPS13D PLXNC1 ARID2 ATAD2B RP1 LRBA CAMSAP1 | 2.82e-04 | 617 | 104 | 11 | GO:0022411 |
| GeneOntologyBiologicalProcess | central nervous system development | HSPG2 RELN MYCBP2 INHBB DISC1 ARID1A GBA2 WDR47 NCOR1 CLU MTOR PTPRZ1 NAV2 PAX7 PBX2 TRAPPC9 | 3.17e-04 | 1197 | 104 | 16 | GO:0007417 |
| GeneOntologyBiologicalProcess | microtubule polymerization | 3.17e-04 | 117 | 104 | 5 | GO:0046785 | |
| GeneOntologyBiologicalProcess | T-helper cell lineage commitment | 3.34e-04 | 27 | 104 | 3 | GO:0002295 | |
| GeneOntologyBiologicalProcess | microtubule depolymerization | 3.46e-04 | 66 | 104 | 4 | GO:0007019 | |
| GeneOntologyBiologicalProcess | positive regulation of DNA-binding transcription factor activity | 3.59e-04 | 261 | 104 | 7 | GO:0051091 | |
| GeneOntologyBiologicalProcess | response to Thyroglobulin triiodothyronine | 3.73e-04 | 6 | 104 | 2 | GO:1904016 | |
| GeneOntologyBiologicalProcess | lymphocyte differentiation | 3.84e-04 | 537 | 104 | 10 | GO:0030098 | |
| GeneOntologyBiologicalProcess | axon development | HSPG2 RELN FN1 MAP1B MYCBP2 DISC1 WDR47 PTPRF PLXNC1 PTPRZ1 SMAD4 | 3.95e-04 | 642 | 104 | 11 | GO:0061564 |
| GeneOntologyBiologicalProcess | regulation of microtubule polymerization | 4.10e-04 | 69 | 104 | 4 | GO:0031113 | |
| GeneOntologyBiologicalProcess | positive regulation of neurogenesis | 4.28e-04 | 354 | 104 | 8 | GO:0050769 | |
| GeneOntologyBiologicalProcess | cerebral cortex radial glia-guided migration | 4.58e-04 | 30 | 104 | 3 | GO:0021801 | |
| GeneOntologyBiologicalProcess | telencephalon glial cell migration | 4.58e-04 | 30 | 104 | 3 | GO:0022030 | |
| GeneOntologyBiologicalProcess | positive regulation of cellular component organization | SLAIN2 TPR RELN FN1 MAP1B DISC1 CRTC1 WNK1 VPS13D PTPRF CLU PLXNC1 MTOR PTPRZ1 RP1 GRIP2 SMAD4 | 4.63e-04 | 1366 | 104 | 17 | GO:0051130 |
| GeneOntologyBiologicalProcess | CD4-positive, alpha-beta T cell lineage commitment | 5.05e-04 | 31 | 104 | 3 | GO:0043373 | |
| GeneOntologyBiologicalProcess | positive regulation of neuron maturation | 5.20e-04 | 7 | 104 | 2 | GO:0014042 | |
| GeneOntologyBiologicalProcess | positive regulation of follicle-stimulating hormone secretion | 5.20e-04 | 7 | 104 | 2 | GO:0046881 | |
| GeneOntologyBiologicalProcess | axonogenesis | 5.79e-04 | 566 | 104 | 10 | GO:0007409 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | RELN FN1 MAP1B DISC1 ARID1A PTPRF CLU PLXNC1 MTOR PTPRZ1 ARID2 FAM210B CD40LG GRIP2 SMAD4 | 5.90e-04 | 1141 | 104 | 15 | GO:0045597 |
| GeneOntologyBiologicalProcess | eye morphogenesis | 5.90e-04 | 204 | 104 | 6 | GO:0048592 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | HSPG2 MUC19 HIPK2 DYNC2I1 FGFRL1 BCOR ARID1A ZHX2 PRDM1 FAT1 MTOR ARID2 RP1 PAX7 PBX2 SMAD4 | 6.01e-04 | 1269 | 104 | 16 | GO:0009887 |
| GeneOntologyBiologicalProcess | alpha-beta T cell lineage commitment | 6.09e-04 | 33 | 104 | 3 | GO:0002363 | |
| GeneOntologyBiologicalProcess | heart valve development | 6.53e-04 | 78 | 104 | 4 | GO:0003170 | |
| GeneOntologyBiologicalProcess | response to temperature stimulus | 6.54e-04 | 208 | 104 | 6 | GO:0009266 | |
| GeneOntologyBiologicalProcess | positive regulation of gonadotropin secretion | 6.91e-04 | 8 | 104 | 2 | GO:0032278 | |
| GeneOntologyBiologicalProcess | retina development in camera-type eye | 7.04e-04 | 211 | 104 | 6 | GO:0060041 | |
| GeneOntologyBiologicalProcess | regulation of microtubule-based process | 7.13e-04 | 293 | 104 | 7 | GO:0032886 | |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | HSPG2 RELN FN1 MAP1B MYCBP2 DISC1 WDR47 PTPRF CLU PLXNC1 PTPRZ1 SMAD4 | 7.16e-04 | 802 | 104 | 12 | GO:0048812 |
| GeneOntologyBiologicalProcess | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment | 7.25e-04 | 35 | 104 | 3 | GO:0043369 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex disassembly | 8.17e-04 | 144 | 104 | 5 | GO:0043244 | |
| GeneOntologyBiologicalProcess | T cell activation | SPN MUC19 ARID1A PRDM1 FANCA NCOR1 MTOR ARID2 BTNL2 CD40LG LY9 | 8.19e-04 | 701 | 104 | 11 | GO:0042110 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | HSPG2 RELN FN1 MAP1B MYCBP2 DISC1 WDR47 PTPRF CLU PLXNC1 PTPRZ1 SMAD4 | 8.60e-04 | 819 | 104 | 12 | GO:0120039 |
| GeneOntologyBiologicalProcess | voluntary musculoskeletal movement | 8.86e-04 | 9 | 104 | 2 | GO:0050882 | |
| GeneOntologyBiologicalProcess | regulation of follicle-stimulating hormone secretion | 8.86e-04 | 9 | 104 | 2 | GO:0046880 | |
| GeneOntologyBiologicalProcess | response to insecticide | 8.86e-04 | 9 | 104 | 2 | GO:0017085 | |
| GeneOntologyBiologicalProcess | positive regulation of cell population proliferation | HSPG2 FN1 SPN DISC1 HIPK2 NCOR1 CLU MTOR PTPRZ1 BTNL2 CD40LG CRNN BICRAL PAX7 SMAD4 | 9.07e-04 | 1190 | 104 | 15 | GO:0008284 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | HSPG2 RELN FN1 MAP1B MYCBP2 DISC1 WDR47 PTPRF CLU PLXNC1 PTPRZ1 SMAD4 | 9.26e-04 | 826 | 104 | 12 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | SPN FGFRL1 ADGRV1 ARID1A WNK1 FAT1 PTPRF ARVCF MTOR ARID2 BTNL2 CD40LG CRNN MUC4 | 1.01e-03 | 1077 | 104 | 14 | GO:0098609 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | SLAIN2 TPR MAP1B ODAD1 DISC1 GBA2 WDR47 NCOR1 RP1L1 RP1 CAMSAP1 | 1.02e-03 | 720 | 104 | 11 | GO:0000226 |
| GeneOntologyBiologicalProcess | supramolecular fiber organization | SLAIN2 HSPG2 MAP1B WASHC3 GBA2 WDR47 FAT1 CLU MTOR LTBP2 RP1 CAMSAP1 SMAD4 | 1.04e-03 | 957 | 104 | 13 | GO:0097435 |
| GeneOntologyBiologicalProcess | regulation of neuron projection development | 1.05e-03 | 612 | 104 | 10 | GO:0010975 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 1.07e-03 | 89 | 104 | 4 | GO:1901880 | |
| GeneOntologyBiologicalProcess | regulation of chromatin organization | 1.07e-03 | 40 | 104 | 3 | GO:1902275 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | SLAIN2 TPR RNF186 MAP1B MYCBP2 WASHC3 ARID1A GBA2 WDR47 VPS13D CLU MTOR ARID2 RP1 CAMSAP1 SMAD4 | 1.09e-03 | 1342 | 104 | 16 | GO:0033043 |
| GeneOntologyBiologicalProcess | retina morphogenesis in camera-type eye | 1.12e-03 | 90 | 104 | 4 | GO:0060042 | |
| GeneOntologyBiologicalProcess | sensory organ development | INHBB HIPK2 ADGRV1 ARID1A ZHX2 PRDM1 FAT1 RP1L1 RP1 GNB1 PBX2 | 1.14e-03 | 730 | 104 | 11 | GO:0007423 |
| GeneOntologyBiologicalProcess | hemopoiesis | SPN MUC19 HIPK2 ARID1A PRDM1 FANCA NCOR1 MTOR PTPRZ1 ARID2 FAM210B CD40LG LY9 HERC6 MUC4 | 1.19e-03 | 1223 | 104 | 15 | GO:0030097 |
| GeneOntologyBiologicalProcess | alpha-beta T cell differentiation | 1.20e-03 | 157 | 104 | 5 | GO:0046632 | |
| GeneOntologyBiologicalProcess | cerebral cortex radially oriented cell migration | 1.24e-03 | 42 | 104 | 3 | GO:0021799 | |
| GeneOntologyBiologicalProcess | T cell lineage commitment | 1.24e-03 | 42 | 104 | 3 | GO:0002360 | |
| GeneOntologyBiologicalProcess | negative regulation of catabolic process | 1.26e-03 | 418 | 104 | 8 | GO:0009895 | |
| GeneOntologyBiologicalProcess | positive regulation of nervous system development | 1.26e-03 | 418 | 104 | 8 | GO:0051962 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | TPR FBLL1 HIPK2 BCOR ARID1A SETD5 ARID2 ATAD2B MCM3AP BICRAL PAX7 | 1.28e-03 | 741 | 104 | 11 | GO:0006338 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | 1.32e-03 | 421 | 104 | 8 | GO:0010639 | |
| GeneOntologyBiologicalProcess | regulation of mRNA export from nucleus | 1.34e-03 | 11 | 104 | 2 | GO:0010793 | |
| GeneOntologyBiologicalProcess | follicle-stimulating hormone secretion | 1.34e-03 | 11 | 104 | 2 | GO:0046884 | |
| GeneOntologyBiologicalProcess | endocrine system development | 1.34e-03 | 161 | 104 | 5 | GO:0035270 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | HSPG2 RELN FN1 MAP1B MYCBP2 DISC1 WDR47 PTPRF PLXNC1 PTPRZ1 SMAD4 | 1.38e-03 | 748 | 104 | 11 | GO:0048667 |
| GeneOntologyBiologicalProcess | camera-type eye development | 1.42e-03 | 426 | 104 | 8 | GO:0043010 | |
| GeneOntologyBiologicalProcess | mononuclear cell differentiation | 1.47e-03 | 640 | 104 | 10 | GO:1903131 | |
| GeneOntologyBiologicalProcess | protein polymerization | 1.52e-03 | 334 | 104 | 7 | GO:0051258 | |
| GeneOntologyBiologicalProcess | dendrite development | 1.55e-03 | 335 | 104 | 7 | GO:0016358 | |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 1.59e-03 | 99 | 104 | 4 | GO:0021954 | |
| GeneOntologyBiologicalProcess | negative regulation of cell adhesion mediated by integrin | 1.61e-03 | 12 | 104 | 2 | GO:0033629 | |
| GeneOntologyCellularComponent | Golgi lumen | 1.29e-06 | 109 | 105 | 7 | GO:0005796 | |
| GeneOntologyCellularComponent | extracellular matrix | HSPG2 RELN FN1 SPN MUC5B TGM4 OVGP1 CLU PTPRZ1 NAV2 LTBP2 MUC4 MUC5AC | 2.51e-05 | 656 | 105 | 13 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | HSPG2 RELN FN1 SPN MUC5B TGM4 OVGP1 CLU PTPRZ1 NAV2 LTBP2 MUC4 MUC5AC | 2.59e-05 | 658 | 105 | 13 | GO:0030312 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 9.51e-05 | 18 | 105 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 1.24e-04 | 153 | 105 | 6 | GO:0097731 | |
| GeneOntologyCellularComponent | dynein complex | 1.57e-04 | 54 | 105 | 4 | GO:0030286 | |
| GeneOntologyCellularComponent | microtubule associated complex | 1.63e-04 | 161 | 105 | 6 | GO:0005875 | |
| GeneOntologyCellularComponent | cell body | RELN MAP1B DISC1 CRTC1 WDR47 PTPRF MTOR PTPRZ1 KCNK1 CD40LG KCNN3 GRIP2 WDFY3 GNB1 | 2.26e-04 | 929 | 105 | 14 | GO:0044297 |
| GeneOntologyCellularComponent | growth cone | 2.39e-04 | 245 | 105 | 7 | GO:0030426 | |
| GeneOntologyCellularComponent | site of polarized growth | 2.91e-04 | 253 | 105 | 7 | GO:0030427 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 3.37e-04 | 530 | 105 | 10 | GO:0062023 | |
| GeneOntologyCellularComponent | PML body | 4.23e-04 | 125 | 105 | 5 | GO:0016605 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 4.53e-04 | 30 | 105 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | non-motile cilium | 4.69e-04 | 196 | 105 | 6 | GO:0097730 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 6.86e-04 | 139 | 105 | 5 | GO:0097733 | |
| GeneOntologyCellularComponent | inclusion body | 1.10e-03 | 90 | 105 | 4 | GO:0016234 | |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 1.81e-03 | 48 | 105 | 3 | GO:0032391 | |
| GeneOntologyCellularComponent | photoreceptor outer segment | 2.38e-03 | 111 | 105 | 4 | GO:0001750 | |
| GeneOntologyCellularComponent | actin-based cell projection | 2.81e-03 | 278 | 105 | 6 | GO:0098858 | |
| GeneOntologyCellularComponent | neuronal cell body | RELN MAP1B CRTC1 WDR47 PTPRF MTOR PTPRZ1 KCNK1 KCNN3 GRIP2 WDFY3 | 3.17e-03 | 835 | 105 | 11 | GO:0043025 |
| HumanPheno | Abnormal finger morphology | TPR HSPG2 RELN FN1 MAP1B ODAD1 DYNC2I1 FGFRL1 MUC5B BCOR ARID1A WNK1 FANCA ARVCF SETD5 MTOR ARID2 BTNL2 KCNN3 LTBP2 LRBA GNB1 TRAPPC9 SMAD4 | 6.73e-06 | 1385 | 39 | 24 | HP:0001167 |
| HumanPheno | Abnormal fingertip morphology | 1.59e-05 | 203 | 39 | 9 | HP:0001211 | |
| HumanPheno | Abnormal hand morphology | TPR HSPG2 FN1 MAP1B DYNC2I1 FGFRL1 BCOR ARID1A WNK1 FANCA PHYH ARVCF MTOR ARID2 MCM3AP KCNN3 LTBP2 GNB1 TRAPPC9 SMAD4 | 3.13e-05 | 1082 | 39 | 20 | HP:0005922 |
| HumanPheno | Abnormality of the philtrum | TPR HSPG2 MAP1B DYNC2I1 FGFRL1 BCOR ARID1A PTPRF ARVCF SETD5 MTOR ARID2 ANKRD17 GNB1 TRAPPC9 SMAD4 | 3.75e-05 | 726 | 39 | 16 | HP:0000288 |
| HumanPheno | Small earlobe | 4.54e-05 | 27 | 39 | 4 | HP:0000385 | |
| HumanPheno | Abnormality of the urethra | HSPG2 DYNC2I1 FGFRL1 BCOR ARID1A FANCA PTPRF ARVCF SETD5 MTOR ARID2 SMAD4 | 1.15e-04 | 465 | 39 | 12 | HP:0000795 |
| HumanPheno | Short finger | 1.17e-04 | 325 | 39 | 10 | HP:0009381 | |
| HumanPheno | Clubbing | 1.26e-04 | 152 | 39 | 7 | HP:0001217 | |
| HumanPheno | Abnormal male urethral meatus morphology | HSPG2 FGFRL1 BCOR ARID1A FANCA PTPRF ARVCF SETD5 MTOR ARID2 SMAD4 | 1.33e-04 | 399 | 39 | 11 | HP:0032076 |
| HumanPheno | Abnormal palate morphology | HSPG2 FN1 MAP1B DYNC2I1 FGFRL1 BCOR ARID1A FANCA ARVCF SETD5 ARID2 MCM3AP KCNN3 ANKRD17 LTBP2 PAX7 GNB1 CAMSAP1 TRAPPC9 SMAD4 | 1.53e-04 | 1202 | 39 | 20 | HP:0000174 |
| HumanPheno | Brachydactyly | TPR HSPG2 FN1 DYNC2I1 FGFRL1 BCOR ARID1A FANCA SETD5 MTOR ARID2 KCNN3 LTBP2 SMAD4 | 2.56e-04 | 670 | 39 | 14 | HP:0001156 |
| HumanPheno | Brachydactyly (hand) | FN1 FGFRL1 BCOR ARID1A FANCA SETD5 MTOR ARID2 KCNN3 LTBP2 SMAD4 | 2.59e-04 | 430 | 39 | 11 | HP:0100667 |
| HumanPheno | Short digit | TPR HSPG2 FN1 DYNC2I1 FGFRL1 BCOR ARID1A FANCA SETD5 MTOR ARID2 KCNN3 LTBP2 SMAD4 | 2.64e-04 | 672 | 39 | 14 | HP:0011927 |
| HumanPheno | Ventricular septal defect | TPR ODAD1 DYNC2I1 FGFRL1 BCOR ARID1A ARVCF SETD5 TKT ARID2 LTBP2 SMAD4 | 2.77e-04 | 510 | 39 | 12 | HP:0001629 |
| HumanPheno | Aplasia/Hypoplasia of fingers | 3.12e-04 | 366 | 39 | 10 | HP:0006265 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 3.26e-04 | 368 | 39 | 10 | HP:0031432 | |
| HumanPheno | Abnormal ventricular septum morphology | TPR ODAD1 DYNC2I1 FGFRL1 BCOR ARID1A ARVCF SETD5 TKT ARID2 LTBP2 SMAD4 | 3.39e-04 | 521 | 39 | 12 | HP:0010438 |
| HumanPheno | Orofacial cleft | HSPG2 DYNC2I1 FGFRL1 BCOR ARID1A FANCA ARVCF SETD5 ARID2 KCNN3 ANKRD17 GNB1 TRAPPC9 SMAD4 | 3.72e-04 | 694 | 39 | 14 | HP:0000202 |
| HumanPheno | Craniofacial cleft | HSPG2 DYNC2I1 FGFRL1 BCOR ARID1A FANCA ARVCF SETD5 ARID2 KCNN3 ANKRD17 GNB1 TRAPPC9 SMAD4 | 3.72e-04 | 694 | 39 | 14 | HP:5201015 |
| HumanPheno | Abnormal cardiac septum morphology | TPR HSPG2 RELN ODAD1 DYNC2I1 FGFRL1 BCOR ARID1A FANCA ARVCF SETD5 TKT ARID2 LTBP2 SMAD4 | 3.92e-04 | 787 | 39 | 15 | HP:0001671 |
| HumanPheno | Hypospadias | 3.97e-04 | 377 | 39 | 10 | HP:0000047 | |
| HumanPheno | Perseverative thought | 3.97e-04 | 377 | 39 | 10 | HP:0030223 | |
| HumanPheno | Abnormal upper lip morphology | TPR HSPG2 MAP1B DYNC2I1 FGFRL1 BCOR ARID1A PTPRF ARVCF SETD5 MTOR ARID2 ANKRD17 GNB1 CAMSAP1 TRAPPC9 SMAD4 | 4.14e-04 | 980 | 39 | 17 | HP:0000177 |
| HumanPheno | Patent ductus arteriosus | 4.41e-04 | 382 | 39 | 10 | HP:0001643 | |
| HumanPheno | Aplasia/hypoplasia involving bones of the hand | FN1 DYNC2I1 FGFRL1 BCOR ARID1A FANCA PHYH MTOR ARID2 KCNN3 LTBP2 SMAD4 | 4.57e-04 | 538 | 39 | 12 | HP:0005927 |
| HumanPheno | Disordered formal thought process | 4.80e-04 | 386 | 39 | 10 | HP:0025769 | |
| MousePheno | abnormal fornicate gyrus morphology | 6.31e-06 | 19 | 92 | 4 | MP:0004169 | |
| MousePheno | abnormal forebrain development | 1.69e-05 | 225 | 92 | 9 | MP:0003232 | |
| MousePheno | abnormal telencephalon development | 1.90e-05 | 126 | 92 | 7 | MP:0000934 | |
| MousePheno | abnormal thalamus morphology | 2.71e-05 | 54 | 92 | 5 | MP:0000832 | |
| MousePheno | abnormal forebrain morphology | HSPG2 RELN MAP1B MYCBP2 DISC1 HIPK2 DYNC2I1 FGFRL1 BCOR ARHGAP11A ARID1A NCOR1 SETD5 MTOR CD40LG WDFY3 GNB1 CAMSAP1 TRAPPC9 | 5.78e-05 | 1072 | 92 | 19 | MP:0000783 |
| MousePheno | small thalamus | 9.53e-05 | 14 | 92 | 3 | MP:0020527 | |
| MousePheno | abnormal diencephalon morphology | 1.49e-04 | 298 | 92 | 9 | MP:0000830 | |
| Domain | VWD | 1.29e-06 | 16 | 99 | 4 | SM00216 | |
| Domain | VWF_type-D | 1.29e-06 | 16 | 99 | 4 | IPR001846 | |
| Domain | VWFD | 1.29e-06 | 16 | 99 | 4 | PS51233 | |
| Domain | VWD | 1.29e-06 | 16 | 99 | 4 | PF00094 | |
| Domain | - | 1.13e-05 | 95 | 99 | 6 | 2.60.120.200 | |
| Domain | Aquaporin_12 | 2.78e-05 | 2 | 99 | 2 | IPR023265 | |
| Domain | TIL | 3.07e-05 | 12 | 99 | 3 | PF01826 | |
| Domain | C8 | 3.07e-05 | 12 | 99 | 3 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 3.98e-05 | 13 | 99 | 3 | IPR014853 | |
| Domain | C8 | 3.98e-05 | 13 | 99 | 3 | SM00832 | |
| Domain | TIL_dom | 5.04e-05 | 14 | 99 | 3 | IPR002919 | |
| Domain | EGF_1 | 6.35e-05 | 255 | 99 | 8 | PS00022 | |
| Domain | Aquaporin_11/12 | 8.32e-05 | 3 | 99 | 2 | IPR016697 | |
| Domain | CTCK_1 | 1.11e-04 | 18 | 99 | 3 | PS01185 | |
| Domain | VWC_out | 1.32e-04 | 19 | 99 | 3 | SM00215 | |
| Domain | SEA | 2.07e-04 | 22 | 99 | 3 | PF01390 | |
| Domain | CT | 2.07e-04 | 22 | 99 | 3 | SM00041 | |
| Domain | SEA | 2.37e-04 | 23 | 99 | 3 | PS50024 | |
| Domain | SEA_dom | 2.37e-04 | 23 | 99 | 3 | IPR000082 | |
| Domain | DUF4704 | 2.75e-04 | 5 | 99 | 2 | IPR031570 | |
| Domain | DUF4704 | 2.75e-04 | 5 | 99 | 2 | PF15787 | |
| Domain | Cys_knot_C | 3.05e-04 | 25 | 99 | 3 | IPR006207 | |
| Domain | CTCK_2 | 3.05e-04 | 25 | 99 | 3 | PS01225 | |
| Domain | Ig-like_fold | HSPG2 FN1 MYCBP2 FGFRL1 TGM4 TREML4 PTPRF PLXNC1 PTPRZ1 BTNL2 ADGRF3 LY9 | 3.53e-04 | 706 | 99 | 12 | IPR013783 |
| Domain | PH_BEACH | 4.11e-04 | 6 | 99 | 2 | PF14844 | |
| Domain | WxxW_domain | 4.11e-04 | 6 | 99 | 2 | IPR025155 | |
| Domain | Mucin2_WxxW | 4.11e-04 | 6 | 99 | 2 | PF13330 | |
| Domain | EGF-like_CS | 4.79e-04 | 261 | 99 | 7 | IPR013032 | |
| Domain | EGF_2 | 5.24e-04 | 265 | 99 | 7 | PS01186 | |
| Domain | DCX | 5.74e-04 | 7 | 99 | 2 | PF03607 | |
| Domain | PH-BEACH_dom | 7.63e-04 | 8 | 99 | 2 | IPR023362 | |
| Domain | - | 7.63e-04 | 8 | 99 | 2 | 2.30.29.40 | |
| Domain | PH_BEACH | 7.63e-04 | 8 | 99 | 2 | PS51783 | |
| Domain | DC | 7.63e-04 | 8 | 99 | 2 | PS50309 | |
| Domain | Doublecortin_dom | 7.63e-04 | 8 | 99 | 2 | IPR003533 | |
| Domain | - | HSPG2 FN1 MYCBP2 FGFRL1 TGM4 TREML4 PTPRF PLXNC1 PTPRZ1 BTNL2 LY9 | 7.69e-04 | 663 | 99 | 11 | 2.60.40.10 |
| Domain | BEACH_dom | 9.77e-04 | 9 | 99 | 2 | IPR000409 | |
| Domain | BEACH | 9.77e-04 | 9 | 99 | 2 | PS50197 | |
| Domain | Beach | 9.77e-04 | 9 | 99 | 2 | PF02138 | |
| Domain | - | 9.77e-04 | 9 | 99 | 2 | 1.10.1540.10 | |
| Domain | Beach | 9.77e-04 | 9 | 99 | 2 | SM01026 | |
| Domain | VWC | 1.07e-03 | 38 | 99 | 3 | SM00214 | |
| Domain | VWFC_2 | 1.07e-03 | 38 | 99 | 3 | PS50184 | |
| Domain | LAM_G_DOMAIN | 1.07e-03 | 38 | 99 | 3 | PS50025 | |
| Domain | ConA-like_dom | 1.10e-03 | 219 | 99 | 6 | IPR013320 | |
| Domain | Laminin_G_2 | 1.24e-03 | 40 | 99 | 3 | PF02210 | |
| Domain | VWF_dom | 1.43e-03 | 42 | 99 | 3 | IPR001007 | |
| Domain | EGF_3 | 1.58e-03 | 235 | 99 | 6 | PS50026 | |
| Domain | EGF | 1.58e-03 | 235 | 99 | 6 | SM00181 | |
| Domain | LamG | 1.63e-03 | 44 | 99 | 3 | SM00282 | |
| Domain | EGF-like_dom | 2.11e-03 | 249 | 99 | 6 | IPR000742 | |
| Domain | SEA | 2.43e-03 | 14 | 99 | 2 | SM00200 | |
| Domain | MIP | 2.43e-03 | 14 | 99 | 2 | PS00221 | |
| Domain | MIP | 2.43e-03 | 14 | 99 | 2 | PF00230 | |
| Domain | - | 2.79e-03 | 15 | 99 | 2 | 1.10.150.60 | |
| Domain | MIP | 2.79e-03 | 15 | 99 | 2 | IPR000425 | |
| Domain | BRIGHT | 2.79e-03 | 15 | 99 | 2 | SM00501 | |
| Domain | ARID_dom | 2.79e-03 | 15 | 99 | 2 | IPR001606 | |
| Domain | ARID | 2.79e-03 | 15 | 99 | 2 | PS51011 | |
| Domain | - | 2.79e-03 | 15 | 99 | 2 | 1.20.1080.10 | |
| Domain | Glyco_hormone_CN | 2.79e-03 | 15 | 99 | 2 | IPR006208 | |
| Domain | ARID | 2.79e-03 | 15 | 99 | 2 | PF01388 | |
| Domain | Cys_knot | 2.79e-03 | 15 | 99 | 2 | PF00007 | |
| Domain | Aquaporin-like | 2.79e-03 | 15 | 99 | 2 | IPR023271 | |
| Domain | ARM-like | 3.15e-03 | 270 | 99 | 6 | IPR011989 | |
| Domain | Laminin_G | 3.61e-03 | 58 | 99 | 3 | IPR001791 | |
| Domain | EGF | 4.54e-03 | 126 | 99 | 4 | PF00008 | |
| Domain | RCC1 | 4.97e-03 | 20 | 99 | 2 | PF00415 | |
| Domain | - | 4.97e-03 | 20 | 99 | 2 | 3.60.15.10 | |
| Domain | Metallo-B-lactamas | 4.97e-03 | 20 | 99 | 2 | IPR001279 | |
| Pathway | REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC | 1.45e-08 | 16 | 74 | 5 | M27410 | |
| Pathway | REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS | 2.05e-08 | 17 | 74 | 5 | M27412 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 6.62e-08 | 21 | 74 | 5 | MM15706 | |
| Pathway | REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS | 1.09e-07 | 23 | 74 | 5 | M556 | |
| Pathway | REACTOME_DECTIN_2_FAMILY | 2.10e-07 | 26 | 74 | 5 | M27483 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.52e-05 | 60 | 74 | 5 | MM15636 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | 1.78e-05 | 62 | 74 | 5 | M546 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.80e-05 | 68 | 74 | 5 | M27303 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.03e-04 | 143 | 74 | 6 | M27275 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.66e-04 | 109 | 74 | 5 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 2.89e-04 | 111 | 74 | 5 | M27416 | |
| Pubmed | Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux. | 6.18e-14 | 18 | 106 | 7 | 18834073 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HSPG2 MYCBP2 FGFRL1 ARID1A WNK1 GBA2 FANCA NCOR1 MYOF FAT1 EIF4ENIF1 PTPRF ARVCF SETD5 MTOR MCM3AP NAV2 WDFY3 LRBA CAMSAP1 TRAPPC9 | 1.78e-11 | 1105 | 106 | 21 | 35748872 |
| Pubmed | 1.22e-09 | 6 | 106 | 4 | 19110483 | ||
| Pubmed | SLAIN2 TPR FBLL1 MAP1B MYCBP2 RBBP6 ZNF318 BCOR ARID1A GPRIN1 NCOR1 ARID2 OSBPL11 LRBA | 1.42e-09 | 549 | 106 | 14 | 38280479 | |
| Pubmed | TPR RGPD2 MYCBP2 CRTC1 ZNF318 BCOR NCOR1 EIF4ENIF1 ZNF532 ANKRD17 LRBA CAMSAP1 | 6.18e-09 | 418 | 106 | 12 | 34709266 | |
| Pubmed | TPR RBBP6 HIPK2 CRTC1 MUC12 WNK1 ARID2 MCM3AP NAV2 ANKRD17 BICRAL ZHX1 | 3.25e-08 | 486 | 106 | 12 | 20936779 | |
| Pubmed | TPR RGPD2 MYCBP2 ZNF318 BCOR WDR47 NCOR1 CNTNAP5 ARVCF CLU MTOR ANKRD17 WDFY3 GNB1 CAMSAP1 | 2.40e-07 | 963 | 106 | 15 | 28671696 | |
| Pubmed | Polymorphism of human mucin genes in chest disease: possible significance of MUC2. | 2.74e-07 | 5 | 106 | 3 | 11062147 | |
| Pubmed | SLAIN2 FBLL1 RBBP6 ZNF318 BCOR ARID1A FAT1 EIF4ENIF1 CLU SETD5 ARID2 MCM3AP CRNN ANKRD17 BICRAL WDFY3 | 2.79e-07 | 1116 | 106 | 16 | 31753913 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | TPR MYCBP2 RBBP6 ZNF318 BCOR GPRIN1 NCOR1 MYOF TKT OSBPL11 EIF5B ANKRD17 ZHX1 | 7.07e-07 | 774 | 106 | 13 | 15302935 |
| Pubmed | 8.21e-07 | 242 | 106 | 8 | 34011540 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | RBBP6 DISC1 WNK1 NCOR1 EIF4ENIF1 ZNF532 ARID2 PAX7 CAMSAP1 ZHX1 | 8.33e-07 | 430 | 106 | 10 | 35044719 |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | TPR MAP1B RBBP6 ZNF318 BCOR GPRIN1 WNK1 TKT ARID2 OSBPL11 EIF5B ANKRD17 LRBA CAMSAP1 | 9.87e-07 | 934 | 106 | 14 | 33916271 |
| Pubmed | HSPG2 RBBP6 HIPK2 ZNF318 BCOR ARID1A ZHX2 PRDM1 NCOR1 FAT1 EIF4ENIF1 ARID2 ANKRD17 PAX7 PBX2 ZHX1 TRAPPC9 | 1.51e-06 | 1429 | 106 | 17 | 35140242 | |
| Pubmed | Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer. | 1.62e-06 | 184 | 106 | 7 | 32908313 | |
| Pubmed | 2.10e-06 | 30 | 106 | 4 | 18055048 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 2.21e-06 | 123 | 106 | 6 | 26912792 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | SLAIN2 TNK1 PDE3B MAP1B MYCBP2 CRTC1 WNK1 VPS13D MTOR NAV2 ANKRD17 CAMSAP1 TRAPPC9 | 2.29e-06 | 861 | 106 | 13 | 36931259 |
| Pubmed | 3.88e-06 | 399 | 106 | 9 | 35987950 | ||
| Pubmed | TPR FN1 MAP1B MYCBP2 ZNF318 ARID1A MTOR ATAD2B MCM3AP EIF5B ANKRD17 | 5.21e-06 | 653 | 106 | 11 | 22586326 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 5.28e-06 | 220 | 106 | 7 | 35785414 | |
| Pubmed | TPR FN1 HIPK2 WASHC3 CRTC1 ZNF318 IRGQ BCOR WNK1 TGM4 SETD5 OSBPL11 ANKRD17 TMEM131 | 5.53e-06 | 1084 | 106 | 14 | 11544199 | |
| Pubmed | 6.12e-06 | 225 | 106 | 7 | 12168954 | ||
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 6.30e-06 | 226 | 106 | 7 | 37839992 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7513696 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 37146737 | ||
| Pubmed | MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions. | 9.20e-06 | 2 | 106 | 2 | 14988081 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 15563276 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27855784 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17621824 | ||
| Pubmed | MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer. | 9.20e-06 | 2 | 106 | 2 | 18475301 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22220206 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24317696 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 22391959 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23281133 | ||
| Pubmed | Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules. | 9.20e-06 | 2 | 106 | 2 | 35776514 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24327612 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23836919 | ||
| Pubmed | Gel-forming mucins form distinct morphologic structures in airways. | 9.20e-06 | 2 | 106 | 2 | 28607090 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31030254 | ||
| Pubmed | The idiopathic pulmonary fibrosis honeycomb cyst contains a mucocilary pseudostratified epithelium. | 9.20e-06 | 2 | 106 | 2 | 23527003 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16540890 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 3665768 | ||
| Pubmed | Identification and cloning of a CD43-associated serine/threonine kinase. | 9.20e-06 | 2 | 106 | 2 | 11078605 | |
| Pubmed | Abnormalities in MUC5AC and MUC5B Protein in Airway Mucus in Asthma. | 9.20e-06 | 2 | 106 | 2 | 27845589 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27435107 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 23544943 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 26871672 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 36167651 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19657028 | ||
| Pubmed | mTOR is necessary for proper satellite cell activity and skeletal muscle regeneration. | 9.20e-06 | 2 | 106 | 2 | 25998386 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 14690056 | ||
| Pubmed | In silico cloning of mouse Muc5b gene and upregulation of its expression in mouse asthma model. | 9.20e-06 | 2 | 106 | 2 | 11587997 | |
| Pubmed | Alteration of ocular surface mucins in MUC5AC-DTA transgenic mice. | 9.20e-06 | 2 | 106 | 2 | 19158956 | |
| Pubmed | Pathobiological implications of mucin (MUC) expression in the outcome of small bowel cancer. | 9.20e-06 | 2 | 106 | 2 | 24722639 | |
| Pubmed | Pathophysiological relevance of sputum MUC5AC and MUC5B levels in patients with mild asthma. | 9.20e-06 | 2 | 106 | 2 | 34656442 | |
| Pubmed | Expression of DISC1 binding partners is reduced in schizophrenia and associated with DISC1 SNPs. | 9.20e-06 | 2 | 106 | 2 | 16510495 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 34058148 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18782111 | ||
| Pubmed | Novel homozygous loss-of-function mutations in RP1 and RP1L1 genes in retinitis pigmentosa patients. | 9.20e-06 | 2 | 106 | 2 | 31833436 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 14718370 | ||
| Pubmed | Mucin production during prenatal and postnatal murine lung development. | 9.20e-06 | 2 | 106 | 2 | 21653907 | |
| Pubmed | MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium. | 9.20e-06 | 2 | 106 | 2 | 36427316 | |
| Pubmed | Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells. | 9.20e-06 | 2 | 106 | 2 | 15809071 | |
| Pubmed | Mucin deficiency causes functional and structural changes of the ocular surface. | 9.20e-06 | 2 | 106 | 2 | 23272068 | |
| Pubmed | Younger patients with COME are more likely to have mucoid middle ear fluid containing mucin MUC5B. | 9.20e-06 | 2 | 106 | 2 | 27729120 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 36111525 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 39054516 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19726746 | ||
| Pubmed | Normal murine respiratory tract has its mucus concentrated in clouds based on the Muc5b mucin. | 9.20e-06 | 2 | 106 | 2 | 32348677 | |
| Pubmed | Reassessment of the importance of mucins in determining sputum properties in cystic fibrosis. | 9.20e-06 | 2 | 106 | 2 | 24332705 | |
| Pubmed | HIPK2 VPS13D PLXNC1 ATAD2B OSBPL11 DIO2 GRIP2 WDFY3 GNB1 LY9 | 9.77e-06 | 568 | 106 | 10 | 9110174 | |
| Pubmed | 9.77e-06 | 14 | 106 | 3 | 14702098 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | 9.92e-06 | 569 | 106 | 10 | 30639242 | |
| Pubmed | A "double adaptor" method for improved shotgun library construction. | HIPK2 VPS13D PLXNC1 ATAD2B OSBPL11 DIO2 GRIP2 WDFY3 GNB1 LY9 | 1.07e-05 | 574 | 106 | 10 | 8619474 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PDE3B MAP1B MYCBP2 HIPK2 DYNC2I1 FGFRL1 WASHC3 ADGRV1 ARID1A ZHX2 ZNF532 SETD5 ANKRD17 LRBA PBX2 TRAPPC9 | 1.14e-05 | 1489 | 106 | 16 | 28611215 |
| Pubmed | SLAIN2 FBLL1 RBBP6 CRTC1 ZNF318 BCOR ZHX2 MYOF EIF4ENIF1 SETD5 ARID2 EIF5B ANKRD17 INTS9 ZHX1 DDX28 | 1.22e-05 | 1497 | 106 | 16 | 31527615 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | 1.27e-05 | 351 | 106 | 8 | 38297188 | |
| Pubmed | 1.50e-05 | 101 | 106 | 5 | 10997877 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | PDE3B FN1 DISC1 MUC19 ARHGAP11A GPRIN1 FANCA ZFYVE28 ATAD2B MCM3AP PBX2 | 1.59e-05 | 736 | 106 | 11 | 29676528 |
| Pubmed | 1.68e-05 | 263 | 106 | 7 | 34702444 | ||
| Pubmed | 2.23e-05 | 497 | 106 | 9 | 23414517 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 2.23e-05 | 497 | 106 | 9 | 36774506 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 33232357 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23053434 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 29286856 | ||
| Pubmed | Role of CLU, PICALM, and TNK1 Genotypes in Aging With and Without Alzheimer's Disease. | 2.76e-05 | 3 | 106 | 2 | 28631188 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30236127 | ||
| Pubmed | MUC16-mediated activation of mTOR and c-Myc reprograms pancreatic cancer metabolism. | 2.76e-05 | 3 | 106 | 2 | 26046375 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 36675209 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 29802623 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 26770020 | ||
| Pubmed | Immunohistochemical localization of syndecan-1 in the dental follicle of postnatal mouse teeth. | 2.76e-05 | 3 | 106 | 2 | 17608588 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28152006 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12741956 | ||
| Pubmed | Regulation of mTOR complex 1 (mTORC1) by raptor Ser863 and multisite phosphorylation. | 2.76e-05 | 3 | 106 | 2 | 19864431 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19553700 | ||
| Pubmed | Resistin upregulates MUC5AC/B mucin gene expression in human airway epithelial cells. | 2.76e-05 | 3 | 106 | 2 | 29604272 | |
| Pubmed | mTOR has distinct functions in generating versus sustaining humoral immunity. | 2.76e-05 | 3 | 106 | 2 | 27760048 | |
| Pubmed | Aquaporin 5 expression increases mucin production in lung adenocarcinoma. | 2.76e-05 | 3 | 106 | 2 | 21455588 | |
| Interaction | TOP3B interactions | HSPG2 MYCBP2 FGFRL1 ARID1A WNK1 GBA2 FANCA NCOR1 MYOF FAT1 EIF4ENIF1 PTPRF ARVCF SETD5 MTOR MCM3AP NAV2 ANKRD17 WDFY3 LRBA CAMSAP1 TRAPPC9 DDX28 | 7.56e-07 | 1470 | 101 | 23 | int:TOP3B |
| Interaction | WWTR1 interactions | SLAIN2 MAP1B MYCBP2 ZNF318 BCOR ARID1A GPRIN1 NCOR1 ARID2 OSBPL11 LRBA | 8.74e-06 | 422 | 101 | 11 | int:WWTR1 |
| Interaction | NUP43 interactions | RBBP6 MUC19 ZNF318 BCOR ARID1A ZHX2 NCOR1 EIF4ENIF1 ZNF532 ARID2 ATAD2B MCM3AP ZHX1 | 1.45e-05 | 625 | 101 | 13 | int:NUP43 |
| Interaction | SNRNP40 interactions | HSPG2 RBBP6 ZNF318 BCOR ARID1A ZHX2 NCOR1 EIF4ENIF1 ZNF532 TKT ARID2 ATAD2B INTS9 | 1.77e-05 | 637 | 101 | 13 | int:SNRNP40 |
| Interaction | NFIX interactions | 1.88e-05 | 227 | 101 | 8 | int:NFIX | |
| Interaction | LHX4 interactions | 2.04e-05 | 166 | 101 | 7 | int:LHX4 | |
| Interaction | ETS1 interactions | 3.29e-05 | 121 | 101 | 6 | int:ETS1 | |
| Interaction | HDAC1 interactions | TPR FN1 MYCBP2 CRTC1 ZNF318 BCOR ARID1A ZHX2 PRDM1 NCOR1 EIF4ENIF1 ANKRD17 LRBA CAMSAP1 ZHX1 PGBD3 SMAD4 | 3.40e-05 | 1108 | 101 | 17 | int:HDAC1 |
| Interaction | GUSBP5 interactions | 3.74e-05 | 75 | 101 | 5 | int:GUSBP5 | |
| Interaction | RCOR1 interactions | TPR MYCBP2 ZNF318 BCOR PRDM1 NCOR1 EIF4ENIF1 ANKRD17 PAX7 LRBA CAMSAP1 | 3.74e-05 | 494 | 101 | 11 | int:RCOR1 |
| Interaction | LHX3 interactions | 4.08e-05 | 185 | 101 | 7 | int:LHX3 | |
| Interaction | KLF5 interactions | 5.69e-05 | 195 | 101 | 7 | int:KLF5 | |
| Interaction | KDM1A interactions | TPR MYCBP2 WASHC3 CRTC1 ZNF318 BCOR PRDM1 NCOR1 EIF4ENIF1 ZNF532 CLU ANKRD17 LRBA CAMSAP1 SMAD4 | 6.78e-05 | 941 | 101 | 15 | int:KDM1A |
| Interaction | FEV interactions | 7.33e-05 | 203 | 101 | 7 | int:FEV | |
| Interaction | HNF4A interactions | 7.33e-05 | 275 | 101 | 8 | int:HNF4A | |
| Interaction | TRIM66 interactions | 7.80e-05 | 205 | 101 | 7 | int:TRIM66 | |
| Interaction | YWHAZ interactions | TNK1 PDE3B FN1 MYCBP2 DISC1 CRTC1 BCOR ARID1A ZHX2 WNK1 NCOR1 VPS13D MTOR TKT NAV2 ANKRD17 WDFY3 CAMSAP1 | 8.92e-05 | 1319 | 101 | 18 | int:YWHAZ |
| Interaction | PAX6 interactions | 9.36e-05 | 366 | 101 | 9 | int:PAX6 | |
| Interaction | PDC interactions | 9.44e-05 | 18 | 101 | 3 | int:PDC | |
| Interaction | TLE3 interactions | 1.15e-04 | 376 | 101 | 9 | int:TLE3 | |
| Interaction | GLI3 interactions | 1.34e-04 | 98 | 101 | 5 | int:GLI3 | |
| Interaction | SS18L1 interactions | 1.34e-04 | 98 | 101 | 5 | int:SS18L1 | |
| Interaction | FOXC1 interactions | 1.51e-04 | 228 | 101 | 7 | int:FOXC1 | |
| Interaction | RNF214 interactions | 1.78e-04 | 104 | 101 | 5 | int:RNF214 | |
| Interaction | SMARCD3 interactions | 2.03e-04 | 107 | 101 | 5 | int:SMARCD3 | |
| Interaction | CSTL1 interactions | 2.05e-04 | 58 | 101 | 4 | int:CSTL1 | |
| Interaction | ITGB3 interactions | 2.16e-04 | 170 | 101 | 6 | int:ITGB3 | |
| Interaction | CELA1 interactions | 2.29e-04 | 24 | 101 | 3 | int:CELA1 | |
| Interaction | STATH interactions | 2.34e-04 | 60 | 101 | 4 | int:STATH | |
| GeneFamily | CD molecules|Mucins | 1.31e-12 | 21 | 72 | 7 | 648 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 5.53e-04 | 9 | 72 | 2 | 1230 | |
| GeneFamily | Doublecortin superfamily | 6.89e-04 | 10 | 72 | 2 | 1369 | |
| GeneFamily | Aquaporins | 1.38e-03 | 14 | 72 | 2 | 305 | |
| GeneFamily | AT-rich interaction domain containing | 1.59e-03 | 15 | 72 | 2 | 418 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 1.59e-03 | 15 | 72 | 2 | 529 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.13e-03 | 21 | 72 | 2 | 813 | |
| GeneFamily | WD repeat domain containing | 3.91e-03 | 262 | 72 | 5 | 362 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 6.75e-03 | 31 | 72 | 2 | 81 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.03e-07 | 170 | 104 | 8 | M5880 | |
| Coexpression | NABA_ECM_AFFILIATED | 3.29e-06 | 158 | 104 | 7 | MM17063 | |
| Coexpression | DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP | 8.72e-06 | 340 | 104 | 9 | M2012 | |
| Coexpression | NABA_MATRISOME | HSPG2 RELN FN1 INHBB MUC19 MUC16 MUC5B MUC12 TGM4 OVGP1 PLXNC1 CRNN LTBP2 MUC4 MUC5AC | 1.29e-05 | 1026 | 104 | 15 | M5889 |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.49e-05 | 199 | 104 | 7 | M5201 | |
| Coexpression | GSE29164_CD8_TCELL_VS_CD8_TCELL_AND_IL12_TREATED_MELANOMA_DAY3_DN | 1.54e-05 | 200 | 104 | 7 | M8504 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HDA | 3.39e-05 | 506 | 104 | 10 | M39067 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | MAP1B MYCBP2 INHBB ARHGAP11A ZHX2 MYOF FAT1 ATAD2B ANKRD17 TMEM131 BICRAL WDFY3 SMAD4 | 3.47e-05 | 856 | 104 | 13 | M4500 |
| Coexpression | NABA_MATRISOME | HSPG2 RELN FN1 INHBB MUC19 MUC16 MUC5B TGM4 OVGP1 PLXNC1 CRNN LTBP2 MUC4 MUC5AC | 4.49e-05 | 1008 | 104 | 14 | MM17056 |
| Coexpression | GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP | 4.52e-05 | 161 | 104 | 6 | M7728 | |
| Coexpression | GSE4590_SMALL_VS_LARGE_PRE_BCELL_UP | 7.18e-05 | 175 | 104 | 6 | M6872 | |
| Coexpression | WIEDERSCHAIN_TARGETS_OF_BMI1_AND_PCGF2 | 7.86e-05 | 57 | 104 | 4 | M2316 | |
| Coexpression | GSE3982_MAC_VS_EFF_MEMORY_CD4_TCELL_DN | 1.34e-04 | 196 | 104 | 6 | M5504 | |
| Coexpression | GSE2770_IL12_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | 1.45e-04 | 199 | 104 | 6 | M6060 | |
| Coexpression | GSE36078_UNTREATED_VS_AD5_INF_IL1R_KO_MOUSE_LUNG_DC_UP | 1.49e-04 | 200 | 104 | 6 | M9301 | |
| Coexpression | GSE29949_CD8_NEG_DC_SPLEEN_VS_DC_BRAIN_DN | 1.49e-04 | 200 | 104 | 6 | M8403 | |
| Coexpression | GSE17721_LPS_VS_CPG_1H_BMDC_UP | 1.49e-04 | 200 | 104 | 6 | M3984 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.57e-04 | 68 | 104 | 4 | M1373 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 1.59e-04 | 610 | 104 | 10 | M3854 | |
| Coexpression | MARTINEZ_TP53_TARGETS_DN | 1.70e-04 | 615 | 104 | 10 | M8673 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_EXTRAVILLOUS_TROPHOBLASTS | 1.75e-04 | 70 | 104 | 4 | M40277 | |
| Coexpression | GOTZMANN_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_UP | 1.96e-04 | 72 | 104 | 4 | MM1131 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | INHBB MUC19 MUC16 MUC5B MUC12 TGM4 OVGP1 PLXNC1 CRNN MUC4 MUC5AC | 1.97e-04 | 751 | 104 | 11 | M5885 |
| Coexpression | LINDVALL_IMMORTALIZED_BY_TERT_DN | 2.06e-04 | 73 | 104 | 4 | M1561 | |
| Coexpression | LEE_METASTASIS_AND_ALTERNATIVE_SPLICING_UP | 2.17e-04 | 74 | 104 | 4 | M515 | |
| Coexpression | GSE13522_WT_VS_IFNG_KO_SKIN_UP | 2.28e-04 | 138 | 104 | 5 | M2913 | |
| Coexpression | GSE37532_VISCERAL_ADIPOSE_TISSUE_VS_LN_DERIVED_PPARG_KO_TREG_CD4_TCELL_DN | 2.36e-04 | 139 | 104 | 5 | M8948 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | TPR PDE3B MYCBP2 WNK1 SETD5 ARID2 ATAD2B OSBPL11 ANKRD17 TMEM131 WDFY3 ZHX1 | 1.69e-05 | 564 | 102 | 12 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| ToppCell | Club_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.09e-08 | 193 | 106 | 8 | 9d3165dc5763a07a7d873f497624d9d6528fa2db | |
| ToppCell | wk_15-18-Mesenchymal-Chondrocyte-ASPN+_chondrocyte|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.36e-07 | 178 | 106 | 7 | a55130670aa95a87b833dd3cd2de461d779e4c06 | |
| ToppCell | Ciliated_cells-A-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 2.96e-07 | 184 | 106 | 7 | 07c5a9633ccdcd18771e3230d6198a55c400afa6 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.80e-07 | 191 | 106 | 7 | 9f19098f260d5542aa8ba7eb6f91b44d0db6e0a4 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.80e-07 | 191 | 106 | 7 | fa9f8b50bfc7911c858bc2f9dcd204873d97ac61 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.80e-07 | 191 | 106 | 7 | c4b223b33c020a064f576711a3d700eb60a2d737 | |
| ToppCell | BAL-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.80e-07 | 191 | 106 | 7 | 5129f778a9283bfac4ff322c21c5ca71da4b7174 | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 3.80e-07 | 191 | 106 | 7 | df8a1a6e78aa0cb941b94cb676bd6891d79f3687 | |
| ToppCell | Control-Epithelial|Control / Disease group,lineage and cell class （2021.01.30） | 3.80e-07 | 191 | 106 | 7 | b78547dae8328244a47c83346447bdd787efbcae | |
| ToppCell | BAL-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.80e-07 | 191 | 106 | 7 | c50d6a1a6209ed4157f7c00fc24d4ecb43790f44 | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 4.08e-07 | 193 | 106 | 7 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | Club_cells-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 4.08e-07 | 193 | 106 | 7 | 6582c0367052b9d10fb629c383ee0c55872afd2d | |
| ToppCell | Epithelial_cells-Club_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 4.37e-07 | 195 | 106 | 7 | b758676abfc4e6930b696d270ecc0ea461b87a54 | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 5.01e-07 | 199 | 106 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.80e-06 | 165 | 106 | 6 | 1dcd6b8aa192baeaa1f7bb334843edab6049b96f | |
| ToppCell | Ciliated_cells-A-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.00e-06 | 167 | 106 | 6 | edb722ee9b6ccd00fb038f702be8664020932659 | |
| ToppCell | Ciliated_cells-A-Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 4.62e-06 | 180 | 106 | 6 | d9be152773fe9f2160edad9246fa03c03afeafd6 | |
| ToppCell | COPD-Epithelial-Goblet|World / Disease state, Lineage and Cell class | 5.57e-06 | 186 | 106 | 6 | d75fe7640a4b2c450c9759a1b3c3ef2a087f0092 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 5.57e-06 | 186 | 106 | 6 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.30e-06 | 190 | 106 | 6 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 6.30e-06 | 190 | 106 | 6 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 6.49e-06 | 191 | 106 | 6 | 7b5da29109aa28768c67653a1bc0f385c2d2269b | |
| ToppCell | Healthy_Control-Epithelial-Epithelial-|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.49e-06 | 191 | 106 | 6 | 28caedb2e448e0c7f494100d714fa7cdcf150691 | |
| ToppCell | BAL-Control-Epithelial-Epithelial-Ciliated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 6.49e-06 | 191 | 106 | 6 | b4e335e798c9617356b8e24412f9270c42dce656 | |
| ToppCell | Healthy_Control-Epithelial-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.49e-06 | 191 | 106 | 6 | 15b9386b26caaa7d15f704c4a18881e1ce918a21 | |
| ToppCell | Healthy_Control-Epithelial|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 6.49e-06 | 191 | 106 | 6 | fdcdadbfc9ccae175abe4de8c7428ac4f6a67fde | |
| ToppCell | Control-Epithelial-Ciliated|Control / Disease group,lineage and cell class （2021.01.30） | 6.49e-06 | 191 | 106 | 6 | cdc08e95a0c8f5c7a8d01b6bbaafdb54ef2f0d12 | |
| ToppCell | COPD-Epithelial|COPD / Disease state, Lineage and Cell class | 6.69e-06 | 192 | 106 | 6 | 0644fad5df18f0021f6f49cca996d8cf47f972ff | |
| ToppCell | COVID-19-lung-Secretory|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.69e-06 | 192 | 106 | 6 | 59261098ccb52306f837f632ebaea45b90ad30fe | |
| ToppCell | COPD-Epithelial-Goblet|COPD / Disease state, Lineage and Cell class | 6.69e-06 | 192 | 106 | 6 | 93b2ca0a97776d28c7e8f1a0642c4b63a5554aab | |
| ToppCell | NS-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 7.30e-06 | 195 | 106 | 6 | b0d782eeee30c797b4da9b3be29b864983fd9e71 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.30e-06 | 195 | 106 | 6 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.52e-06 | 196 | 106 | 6 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 7.52e-06 | 196 | 106 | 6 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 7.52e-06 | 196 | 106 | 6 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 7.52e-06 | 196 | 106 | 6 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 7.74e-06 | 197 | 106 | 6 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | LPS_only-Endothelial-Endothelial-FOXM1|LPS_only / Treatment groups by lineage, cell group, cell type | 7.74e-06 | 197 | 106 | 6 | 038fd92750257d43d5e980fd06d77742b543f11a | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 7.74e-06 | 197 | 106 | 6 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.20e-06 | 199 | 106 | 6 | 1ee4010d8557564e25e8ee00b914c2dfd9037838 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 8.20e-06 | 199 | 106 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | BAL-Mild-Epithelial-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.20e-06 | 199 | 106 | 6 | 1df69c0cb5f759f6a2152521842506a75bb95cae | |
| ToppCell | LPS_only-Epithelial_airway-airway_epithelial-Airway-Club|LPS_only / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 165ac94b2d56072ad43358b5127d77555221e2d8 | |
| ToppCell | Mild-Epithelial-Epithelial-|Mild / Condition, Lineage, Cell class and cell subclass | 8.20e-06 | 199 | 106 | 6 | 81115bbd2c10bfdd38376d2075f03a59c31870d2 | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.20e-06 | 199 | 106 | 6 | afd0df242a93f176438309668a9487be1250d9ca | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Airway-Club|Control_saline / Treatment groups by lineage, cell group, cell type | 8.20e-06 | 199 | 106 | 6 | 5cc8b553a58669a30eb10845beb23983dcdf5a6a | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 8.20e-06 | 199 | 106 | 6 | 74087b4b5e567310fc4ac58fb267ff651a180680 | |
| ToppCell | BAL-Mild-Epithelial|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.20e-06 | 199 | 106 | 6 | 00b5ce099c50a5e1786ce2b3a06ee0931a8205a4 | |
| ToppCell | Mild-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 8.20e-06 | 199 | 106 | 6 | ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 8.20e-06 | 199 | 106 | 6 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | Mild-Epithelial-Epithelial|Mild / Condition, Lineage, Cell class and cell subclass | 8.20e-06 | 199 | 106 | 6 | 91308b255783ad4029e5575028c18d7550832c51 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.20e-06 | 199 | 106 | 6 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Bronchial_Biopsy-Epithelial|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 8.20e-06 | 199 | 106 | 6 | ef5d8917c8d011184830a0b8197afc6266707b37 | |
| ToppCell | Mild_COVID-19-Epithelial|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 8.20e-06 | 199 | 106 | 6 | 72689bda7476930887ae007682fcab27f956f050 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.44e-06 | 200 | 106 | 6 | f5bc7d30aa03dd0f95eb64255bd1a2543be8d327 | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type | 8.44e-06 | 200 | 106 | 6 | f0a6747f6d37ec6d261bd649ac678c39cca5e4c8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.44e-06 | 200 | 106 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 1.99e-05 | 138 | 106 | 5 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | P15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.70e-05 | 147 | 106 | 5 | aba44c7057096483c4293a7ebcf8ccc8baed0231 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 150 | 106 | 5 | 8b781ec3e6c2adf052d46d724e2aef72b0c27d13 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B-Plasma_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 150 | 106 | 5 | 17da17f01a3d41ac7df20f806e3eae30eca06982 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Lymphocytic_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.98e-05 | 150 | 106 | 5 | 8702d5bb419d5e997d388e8f7e0365ba5d1de8d5 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5-Lamp5_Plch2_Dock5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.17e-05 | 152 | 106 | 5 | fed80b467ec9e30c7f98bed6cc4f8c583b715e9e | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.27e-05 | 153 | 106 | 5 | 0ad401cb70b9edfc6ae6ccba6879c6c2b6c4d296 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Lamp5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.43e-05 | 163 | 106 | 5 | 8d17f44faf0549fe71a9a45f811f50d767275414 | |
| ToppCell | droplet-Pancreas-Exocrine-21m|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.69e-05 | 165 | 106 | 5 | c17e00ec9dbe30fcded65a461231dbb13665ddac | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-05 | 166 | 106 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-05 | 166 | 106 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.83e-05 | 166 | 106 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 4.97e-05 | 167 | 106 | 5 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B_+_C|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.26e-05 | 169 | 106 | 5 | 2a35846b0e0be0a19a5a04a86cbd72ce65257c8a | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.41e-05 | 170 | 106 | 5 | dfef8f79960979335b86b4730f224239b40735d5 | |
| ToppCell | 10x_5'_v1-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.41e-05 | 170 | 106 | 5 | fb6098137d010175978596bc382e9ecba9c3891e | |
| ToppCell | droplet-Heart-4Chambers-21m-Hematologic-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 171 | 106 | 5 | e852d0e8589eecf4a2e5fea039b52a67c5d58dbd | |
| ToppCell | wk_20-22-Epithelial-Proximal_epithelial-Proximal_secretory_2|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 5.87e-05 | 173 | 106 | 5 | d1e47c87bd4750801f3531f66a56c5dccb4ea64c | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.87e-05 | 173 | 106 | 5 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_1_(DHH+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.87e-05 | 173 | 106 | 5 | 789ab8b2709f4b8728e3733bc72744e9d92ea5ea | |
| ToppCell | 15-Trachea-Mesenchymal-Mesenchyme_RSPO2+|Trachea / Age, Tissue, Lineage and Cell class | 6.04e-05 | 174 | 106 | 5 | fa0681e91724b9a51ee28b214ea5aa14e62ba1a3 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-05 | 176 | 106 | 5 | 9bc87cd5cda2372e1bce94c9dfd408eb1dfd8d0c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.37e-05 | 176 | 106 | 5 | 3f8274a7ab67f9f8a8923193763a5543cfe4defa | |
| ToppCell | 3'_v3-lymph-node_spleen-Mast-Mast_cell_lympho|lymph-node_spleen / Manually curated celltypes from each tissue | 6.55e-05 | 177 | 106 | 5 | 53040dbeb18574a48e352e4bce252c7c3018762c | |
| ToppCell | Club_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 6.72e-05 | 178 | 106 | 5 | be64d4be23fb96a4cdd7980c58880fdfe817747f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.90e-05 | 179 | 106 | 5 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.09e-05 | 180 | 106 | 5 | 9e09b3dfe344b5d50520711513d389865d73a861 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Multiciliated_(nasal)-Multiciliated_(nasal)_L.0.3.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.09e-05 | 180 | 106 | 5 | 1f1af4474f3f0ac3c0d6b1a6c875c354d36d8eec | |
| ToppCell | wk_20-22-Mesenchymal-Chondrocyte-Resting_chondrocyte|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 7.47e-05 | 182 | 106 | 5 | 03a5a02acd48f0eb210485348bfe0cd21f486215 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.47e-05 | 182 | 106 | 5 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.47e-05 | 182 | 106 | 5 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | Epithelial-lung_goblet_cell|World / Lineage, Cell type, age group and donor | 7.66e-05 | 183 | 106 | 5 | 940cbe298e9c53b5622af09264586ed823d3141f | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.86e-05 | 184 | 106 | 5 | 01c19a830348ab0b9c02c1546a439de70ee10f97 | |
| ToppCell | Club|World / Class top | 8.06e-05 | 185 | 106 | 5 | c3caf789e622ed515d143dc594158d52fdcffaef | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_duct|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.27e-05 | 186 | 106 | 5 | 219b1aeca17503244fabbb780bca58f22c7c0f27 | |
| ToppCell | (5)_Glands_duct|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 8.27e-05 | 186 | 106 | 5 | ad8d5010e5095508f4995e0c6c016a44e8ffb8dd | |
| ToppCell | Substantia_nigra-Neuronal|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 8.27e-05 | 186 | 106 | 5 | 3f889083fcffe516388e9b03a5e23af2010ced33 | |
| ToppCell | COPD-Epithelial-Club|World / Disease state, Lineage and Cell class | 8.27e-05 | 186 | 106 | 5 | 3006f4ab1eaf1eb34c10ca9f7c869603d2d25744 | |
| ToppCell | Club-club-14|World / Class top | 8.48e-05 | 187 | 106 | 5 | 4584de577d3736c89187e522497498e58d381c46 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.48e-05 | 187 | 106 | 5 | 71d99a1a95d3692a2891da49d4a243bae6e07fd0 | |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | 8.70e-05 | 188 | 106 | 5 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-lymphatic_endothelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.70e-05 | 188 | 106 | 5 | 26915db8863f4115b46a81982e187322e21600fd | |
| Drug | Thioguanosine [85-31-4]; Down 200; 12.6uM; MCF7; HT_HG-U133A | TPR TNK1 RBBP6 ARHGAP11A VPS13D ARVCF FAM210B CSNK1G1 OSBPL11 | 2.45e-07 | 190 | 105 | 9 | 2619_DN |
| Drug | Ginkgolide A [15291-75-5]; Up 200; 9.8uM; HL60; HT_HG-U133A | 3.32e-07 | 197 | 105 | 9 | 1324_UP | |
| Drug | okadaic acid tetramethyl ether | 9.47e-07 | 5 | 105 | 3 | CID000147507 | |
| Drug | PNS-DKA | 3.29e-06 | 7 | 105 | 3 | CID009549211 | |
| Drug | Cyclosporin A [59865-13-3]; Down 200; 3.4uM; MCF7; HT_HG-U133A | 3.31e-06 | 194 | 105 | 8 | 4411_DN | |
| Drug | F0447-0125; Up 200; 10uM; MCF7; HT_HG-U133A | 3.31e-06 | 194 | 105 | 8 | 6424_UP | |
| Drug | Enoxacin [74011-58-8]; Down 200; 12.4uM; HL60; HG-U133A | 3.57e-06 | 196 | 105 | 8 | 1597_DN | |
| Drug | (-)-Isoproterenol hydrochloride [5984-95-2]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 3.57e-06 | 196 | 105 | 8 | 3571_UP | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 3.71e-06 | 197 | 105 | 8 | 2641_DN | |
| Drug | Glimepiride [93479-97-1]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.71e-06 | 197 | 105 | 8 | 2809_UP | |
| Drug | Fluorocurarine chloride [22273-09-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 3.85e-06 | 198 | 105 | 8 | 6083_DN | |
| Drug | Midecamycin [35457-80-8]; Down 200; 5uM; MCF7; HT_HG-U133A | 3.85e-06 | 198 | 105 | 8 | 5345_DN | |
| Drug | rosiglitazone maleate; Up 200; 10uM; HL60; HG-U133A | 3.85e-06 | 198 | 105 | 8 | 369_UP | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.46e-05 | 171 | 105 | 7 | 2777_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.64e-05 | 174 | 105 | 7 | 5945_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.76e-05 | 176 | 105 | 7 | 7499_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.04e-05 | 180 | 105 | 7 | 3688_DN | |
| Drug | Forskolin, from Coleus forskohlii; Up 200; 0.5uM; MCF7; HT_HG-U133A | 2.43e-05 | 185 | 105 | 7 | 7055_UP | |
| Drug | cellobiitol | 2.51e-05 | 37 | 105 | 4 | CID000003871 | |
| Drug | 5253409; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 2.88e-05 | 190 | 105 | 7 | 961_UP | |
| Drug | 2-Aminobenzenesulfonamide [3306-62-5]; Down 200; 23.2uM; MCF7; HT_HG-U133A | 3.08e-05 | 192 | 105 | 7 | 3400_DN | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Up 200; 7.8uM; HL60; HG-U133A | 3.19e-05 | 193 | 105 | 7 | 1577_UP | |
| Drug | Methoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 3.29e-05 | 194 | 105 | 7 | 3302_UP | |
| Drug | Sulconazole nitrate [61318-91-0]; Down 200; 8.6uM; HL60; HT_HG-U133A | 3.29e-05 | 194 | 105 | 7 | 3035_DN | |
| Drug | Tamoxifen citrate [54965-24-1]; Down 200; 7uM; HL60; HG-U133A | 3.40e-05 | 195 | 105 | 7 | 1366_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.40e-05 | 195 | 105 | 7 | 3321_UP | |
| Drug | Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 3.52e-05 | 196 | 105 | 7 | 3187_DN | |
| Drug | Gramine [87-52-5]; Up 200; 23uM; PC3; HT_HG-U133A | 3.52e-05 | 196 | 105 | 7 | 3999_UP | |
| Drug | Naltrexone hydrochloride dihydrate [16676-29-2]; Down 200; 9.6uM; PC3; HT_HG-U133A | 3.52e-05 | 196 | 105 | 7 | 5765_DN | |
| Drug | Dehydroisoandosterone 3-acetate [853-23-6]; Down 200; 12.2uM; PC3; HT_HG-U133A | 3.52e-05 | 196 | 105 | 7 | 6673_DN | |
| Drug | inulin | 3.56e-05 | 133 | 105 | 6 | CID000024763 | |
| Drug | Trifluridine [70-00-8]; Down 200; 13.6uM; PC3; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 5819_DN | |
| Drug | Amethopterin (R,S) [59-05-2]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 3214_UP | |
| Drug | Chlorpheniramine maleate [113-92-8]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 6773_DN | |
| Drug | haloperidol; Up 200; 10uM; HL60; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 6203_UP | |
| Drug | Ketorolac tromethamine [74103-07-4]; Down 200; 10.6uM; PC3; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 7286_DN | |
| Drug | Bephenium hydroxynaphthoate [3818-50-6]; Down 200; 9uM; MCF7; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 6466_DN | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.63e-05 | 197 | 105 | 7 | 2307_UP | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; PC3; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 4228_UP | |
| Drug | SB 203580; Up 200; 1uM; MCF7; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 6915_UP | |
| Drug | Hydralazine hydrochloride [304-20-1]; Down 200; 20.4uM; PC3; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 4282_DN | |
| Drug | Torsemide [56211-40-6]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 5476_DN | |
| Drug | Norethynodrel [68-23-5]; Down 200; 13.4uM; PC3; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 1818_DN | |
| Drug | Cefamandole sodium salt [30034-03-8]; Up 200; 8.2uM; MCF7; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 3436_UP | |
| Drug | Trimethoprim [738-70-5]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 4701_UP | |
| Drug | Tocainide hydrochloride; Down 200; 17.4uM; MCF7; HT_HG-U133A | 3.75e-05 | 198 | 105 | 7 | 4838_DN | |
| Drug | Molsidomine [25717-80-0]; Down 200; 16.6uM; MCF7; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 2862_DN | |
| Drug | Eburnamonine (-) [4880-88-0]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 6802_UP | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; PC3; HT_HG-U133A | 3.87e-05 | 199 | 105 | 7 | 7308_UP | |
| Drug | Guanabenz acetate [23256-50-0]; Down 200; 13.8uM; HL60; HG-U133A | 3.87e-05 | 199 | 105 | 7 | 2045_DN | |
| Drug | Althiazide [5588-16-9]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 4.00e-05 | 200 | 105 | 7 | 6829_DN | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 8.35e-05 | 155 | 105 | 6 | 6817_DN | |
| Drug | N-phenylglycolhydroxamate | 1.26e-04 | 4 | 105 | 2 | CID000115251 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.43e-04 | 171 | 105 | 6 | 4954_DN | |
| Drug | SAHA; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 1.43e-04 | 171 | 105 | 6 | 1000_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.43e-04 | 171 | 105 | 6 | 6879_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.48e-04 | 172 | 105 | 6 | 5903_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; PC3; HT_HG-U133A | 1.53e-04 | 173 | 105 | 6 | 5950_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.57e-04 | 174 | 105 | 6 | 6493_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.62e-04 | 175 | 105 | 6 | 5935_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.62e-04 | 175 | 105 | 6 | 6891_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.67e-04 | 176 | 105 | 6 | 5976_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.78e-04 | 178 | 105 | 6 | 1471_DN | |
| Drug | Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A | 1.78e-04 | 178 | 105 | 6 | 3998_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.78e-04 | 178 | 105 | 6 | 6276_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.89e-04 | 180 | 105 | 6 | 6454_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.89e-04 | 180 | 105 | 6 | 4541_DN | |
| Drug | scriptaid; Down 200; 10uM; PC3; HT_HG-U133A | 2.01e-04 | 182 | 105 | 6 | 6896_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.01e-04 | 182 | 105 | 6 | 5802_DN | |
| Drug | clotrimazole; Up 200; 50uM; MCF7; HT_HG-U133A_EA | 2.19e-04 | 185 | 105 | 6 | 905_UP | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 2.19e-04 | 185 | 105 | 6 | 6916_UP | |
| Drug | Diflunisal [22494-42-4]; Down 200; 16uM; HL60; HG-U133A | 2.53e-04 | 190 | 105 | 6 | 1990_DN | |
| Drug | Tropicamide [1508-75-4]; Down 200; 14uM; PC3; HT_HG-U133A | 2.76e-04 | 193 | 105 | 6 | 4280_DN | |
| Drug | oxaprozin; Up 200; 300uM; MCF7; HT_HG-U133A_EA | 2.76e-04 | 193 | 105 | 6 | 971_UP | |
| Drug | Etanidazole [22668-01-5]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 6072_DN | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 5450_DN | |
| Drug | 5230742; Up 200; 17uM; MCF7; HT_HG-U133A_EA | 2.83e-04 | 194 | 105 | 6 | 862_UP | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 4951_UP | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 7534_DN | |
| Drug | H-89, Dihydrochloride; Up 200; 0.5uM; PC3; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 6921_UP | |
| Drug | Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; HL60; HG-U133A | 2.83e-04 | 194 | 105 | 6 | 1759_UP | |
| Drug | Zardaverine [101975-10-4]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 7347_UP | |
| Drug | Hydrocortisone base [50-23-7]; Up 200; 11uM; MCF7; HT_HG-U133A | 2.83e-04 | 194 | 105 | 6 | 3284_UP | |
| Drug | Phenindione [83-12-5]; Up 200; 18uM; MCF7; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 2868_UP | |
| Drug | Naringenine [480-41-1]; Down 200; 14.6uM; PC3; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 4597_DN | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 3862_UP | |
| Drug | Dextromethorphan hydrobromide monohydrate [6700-34-1]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 5401_UP | |
| Drug | Flutamide [13311-84-7]; Down 200; 14.4uM; HL60; HT_HG-U133A | 2.91e-04 | 195 | 105 | 6 | 2358_DN | |
| Drug | Metoprolol-(+,-) (+)-tartrate salt [56392-17-7]; Down 200; 5.8uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 6846_DN | |
| Drug | Acyclovir [59277-89-3]; Down 200; 17.8uM; HL60; HG-U133A | 2.99e-04 | 196 | 105 | 6 | 2044_DN | |
| Drug | Chlormezanone [80-77-3]; Down 200; 14.6uM; HL60; HG-U133A | 2.99e-04 | 196 | 105 | 6 | 1620_DN | |
| Drug | Vancomycin hydrochloride [1404-93-9]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 4423_DN | |
| Drug | Epicatechin-(-) [154-23-4]; Down 200; 13.8uM; PC3; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 4594_DN | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 4357_UP | |
| Drug | Pralidoxime chloride [51-15-0]; Down 200; 23.2uM; HL60; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 3066_DN | |
| Drug | Etilefrine hydrochloride [534-87-2]; Down 200; 18.4uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 4415_DN | |
| Drug | (d,l)-Tetrahydroberberine [522-97-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 2818_DN | |
| Drug | Tocopherol (R,S) [10191-41-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 3256_UP | |
| Drug | Mifepristone [84371-65-3]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 5827_DN | |
| Drug | Bretylium tosylate [61-75-6]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.99e-04 | 196 | 105 | 6 | 3394_UP | |
| Disease | Sjogren's syndrome (is_marker_for) | 1.41e-06 | 24 | 103 | 4 | DOID:12894 (is_marker_for) | |
| Disease | Adenocarcinoma Of Esophagus | 1.46e-05 | 14 | 103 | 3 | C0279628 | |
| Disease | cortical thickness | HSPG2 RELN MYCBP2 FGFRL1 ZNF318 ADGRV1 PHYH VPS13D PTPRF SETD5 PLXNC1 NAV2 TMEM131 PAX7 | 3.28e-05 | 1113 | 103 | 14 | EFO_0004840 |
| Disease | keratoconjunctivitis (is_marker_for) | 3.61e-05 | 3 | 103 | 2 | DOID:9368 (is_marker_for) | |
| Disease | pancreatic ductal carcinoma (is_marker_for) | 6.27e-05 | 61 | 103 | 4 | DOID:3587 (is_marker_for) | |
| Disease | cholangiocarcinoma (is_marker_for) | 7.57e-05 | 64 | 103 | 4 | DOID:4947 (is_marker_for) | |
| Disease | YKL40 measurement, cerebrospinal fluid biomarker measurement | 1.20e-04 | 5 | 103 | 2 | EFO_0004869, EFO_0006794 | |
| Disease | mucinous adenocarcinoma (is_marker_for) | 1.20e-04 | 5 | 103 | 2 | DOID:3030 (is_marker_for) | |
| Disease | Parkinson disease | 1.37e-04 | 321 | 103 | 7 | MONDO_0005180 | |
| Disease | Glioblastoma | 1.72e-04 | 79 | 103 | 4 | C0017636 | |
| Disease | quality of life during menstruation measurement, breast pressure measurement | 1.79e-04 | 6 | 103 | 2 | EFO_0009366, EFO_0009393 | |
| Disease | Giant Cell Glioblastoma | 2.18e-04 | 84 | 103 | 4 | C0334588 | |
| Disease | atherosclerosis (implicated_via_orthology) | 2.51e-04 | 7 | 103 | 2 | DOID:1936 (implicated_via_orthology) | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 2.51e-04 | 7 | 103 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | Embryonal Rhabdomyosarcoma | 3.33e-04 | 8 | 103 | 2 | C0206656 | |
| Disease | common bile duct neoplasm (is_marker_for) | 3.33e-04 | 8 | 103 | 2 | DOID:4608 (is_marker_for) | |
| Disease | Melancholia | 4.00e-04 | 41 | 103 | 3 | C0025193 | |
| Disease | Depression, Neurotic | 4.00e-04 | 41 | 103 | 3 | C0282126 | |
| Disease | Adenoid Cystic Carcinoma | 4.25e-04 | 100 | 103 | 4 | C0010606 | |
| Disease | influenza A severity measurement | 4.28e-04 | 9 | 103 | 2 | EFO_0007743 | |
| Disease | Coffin-Siris syndrome (implicated_via_orthology) | 4.28e-04 | 9 | 103 | 2 | DOID:1925 (implicated_via_orthology) | |
| Disease | Depressive Syndrome | 4.30e-04 | 42 | 103 | 3 | C0086133 | |
| Disease | dry eye syndrome (is_marker_for) | 5.33e-04 | 10 | 103 | 2 | DOID:10140 (is_marker_for) | |
| Disease | otitis media (is_marker_for) | 5.33e-04 | 10 | 103 | 2 | DOID:10754 (is_marker_for) | |
| Disease | lip morphology measurement | 5.39e-04 | 189 | 103 | 5 | EFO_0007845 | |
| Disease | Endogenous depression | 5.62e-04 | 46 | 103 | 3 | C0011573 | |
| Disease | Glioblastoma Multiforme | 6.30e-04 | 111 | 103 | 4 | C1621958 | |
| Disease | pulmonary fibrosis | 6.50e-04 | 11 | 103 | 2 | EFO_0009448 | |
| Disease | Kawasaki disease (is_implicated_in) | 7.78e-04 | 12 | 103 | 2 | DOID:13378 (is_implicated_in) | |
| Disease | Coffin-Siris syndrome | 9.18e-04 | 13 | 103 | 2 | C0265338 | |
| Disease | esophageal adenocarcinoma, Barrett's esophagus, sex interaction measurement | 9.18e-04 | 13 | 103 | 2 | EFO_0000280, EFO_0000478, EFO_0008343 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 9.93e-04 | 447 | 103 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | ovarian cancer (is_implicated_in) | 1.00e-03 | 56 | 103 | 3 | DOID:2394 (is_implicated_in) | |
| Disease | idiopathic pulmonary fibrosis | 1.05e-03 | 57 | 103 | 3 | EFO_0000768 | |
| Disease | Pneumoconiosis | 1.07e-03 | 14 | 103 | 2 | C0032273 | |
| Disease | Bagassosis | 1.07e-03 | 14 | 103 | 2 | C0004681 | |
| Disease | Alzheimer disease, age at onset | 1.31e-03 | 343 | 103 | 6 | EFO_0004847, MONDO_0004975 | |
| Disease | Malignant neoplasm of breast | FN1 ZNF318 ARHGAP11A ARID1A WNK1 NCOR1 ZNF532 MTOR OSBPL11 LRBA PGBD3 | 1.33e-03 | 1074 | 103 | 11 | C0006142 |
| Disease | cystic fibrosis (is_marker_for) | 1.35e-03 | 62 | 103 | 3 | DOID:1485 (is_marker_for) | |
| Disease | Bladder Neoplasm | 1.49e-03 | 140 | 103 | 4 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 1.53e-03 | 141 | 103 | 4 | C0005684 | |
| Disease | triacylglycerol 56:9 measurement | 1.59e-03 | 17 | 103 | 2 | EFO_0010436 | |
| Disease | otitis media (biomarker_via_orthology) | 1.59e-03 | 17 | 103 | 2 | DOID:10754 (biomarker_via_orthology) | |
| Disease | schizophrenia (implicated_via_orthology) | 1.76e-03 | 68 | 103 | 3 | DOID:5419 (implicated_via_orthology) | |
| Disease | photoreceptor cell layer thickness measurement | 1.83e-03 | 148 | 103 | 4 | EFO_0803370 | |
| Disease | carotid artery disease (is_marker_for) | 1.99e-03 | 19 | 103 | 2 | DOID:3407 (is_marker_for) | |
| Disease | anorectal malformation | 1.99e-03 | 19 | 103 | 2 | MONDO_0019938 | |
| Disease | intrahepatic cholangiocarcinoma (is_marker_for) | 1.99e-03 | 19 | 103 | 2 | DOID:4928 (is_marker_for) | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 2.02e-03 | 152 | 103 | 4 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Antihypertensive use measurement | 2.41e-03 | 265 | 103 | 5 | EFO_0009927 | |
| Disease | hypothyroidism (biomarker_via_orthology) | 2.79e-03 | 80 | 103 | 3 | DOID:1459 (biomarker_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 2.79e-03 | 80 | 103 | 3 | DOID:6432 (biomarker_via_orthology) | |
| Disease | otosclerosis | 2.89e-03 | 81 | 103 | 3 | EFO_0004213 | |
| Disease | congestive heart failure (is_marker_for) | 3.00e-03 | 82 | 103 | 3 | DOID:6000 (is_marker_for) | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.17e-03 | 24 | 103 | 2 | C0345905 | |
| Disease | Ureteral obstruction | 3.17e-03 | 24 | 103 | 2 | C0041956 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.17e-03 | 24 | 103 | 2 | C3805278 | |
| Disease | Colorectal Carcinoma | 3.23e-03 | 702 | 103 | 8 | C0009402 | |
| Disease | Left Ventricular Hypertrophy | 3.44e-03 | 25 | 103 | 2 | C0149721 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| QPGTQVSVTSSHGQA | 281 | Q8IZF5 | |
| HGVTLDGASANPTVS | 71 | Q8IXF9 | |
| GTPTSHVSIVTSEDG | 101 | O00192 | |
| VTDPSQVSHGTGFTS | 241 | P29965 | |
| TIPSSSQALTQGSHG | 401 | Q9UIR0 | |
| TANVSIHGTFSLGPS | 5211 | Q8WXG9 | |
| SVVVSPHSTTSVIQG | 1466 | Q68CP9 | |
| HGVTLDGASANPTVS | 71 | A6NM10 | |
| ERDSTGIVTPSGTFH | 2501 | O75179 | |
| SSVETTPSVIQHVGQ | 586 | Q6W2J9 | |
| PTETQIHGGRSSSVE | 551 | Q569K6 | |
| SAATTEPESVHSGGT | 1406 | Q5T5Y3 | |
| PTVTSVRGTSAHFGI | 106 | Q9NRI5 | |
| GTAHTTKVPTTTTTG | 3301 | Q9HC84 | |
| ATSGTLGTTHITEPS | 4031 | Q9HC84 | |
| TGTSHTPAATTGTTQ | 4046 | Q9HC84 | |
| GTAHTTKVPTTTTTG | 4586 | Q9HC84 | |
| TIQGSGSSHVPSVSP | 2616 | P98160 | |
| ATTVPEHASVQAGET | 3301 | P98160 | |
| HTGFTGTVYATEPTV | 116 | Q9NV88 | |
| PTTTISQDGGSTVHR | 311 | P23759 | |
| PHTSGSQVDTASGLQ | 636 | Q9HCC9 | |
| HVTTAEGTPGTTDQE | 1881 | O14497 | |
| VLDQVHTASGTAPGT | 3926 | Q14517 | |
| EITITTQTGPHGATS | 4971 | Q8WXI7 | |
| TQTGPHGATSQDTFT | 4976 | Q8WXI7 | |
| VHPSTNTGGTNVATT | 7766 | Q8WXI7 | |
| NTHTSPLGATTQGTS | 7906 | Q8WXI7 | |
| ATSHGTEAGSAVPTV | 10966 | Q8WXI7 | |
| TTVSGTIPNFSHRGS | 11586 | Q8WXI7 | |
| GFTHRSSVPTTSTGV | 13906 | Q8WXI7 | |
| HSTTLPKTTGAGAQT | 551 | Q99102 | |
| LPVTDASSVSTGHGT | 4161 | Q99102 | |
| ASSVHVPVSALGAGS | 446 | Q8NA72 | |
| AVSVTQGGHSRTSSP | 321 | P40425 | |
| APNSSVVHVSSTEGG | 81 | Q92813 | |
| FPGSTGHIVVTSASS | 86 | Q9H2X6 | |
| VSPSQSVTGSAGHTP | 1321 | P46821 | |
| TANSLGSHTVTGGTI | 121 | P16150 | |
| GSHTVTGGTITTNSP | 126 | P16150 | |
| GLSVTSEQINPHSTG | 1086 | Q9ULI0 | |
| AGVPGSASSFHTAVV | 341 | P09529 | |
| PVGSVHVDSGASAIT | 336 | Q9HCP0 | |
| GGTTIHTASAPSNVT | 1846 | Q5HYC2 | |
| ASTVLSTTGYGHTVP | 111 | O00180 | |
| TQTSSVGPFSGLEHT | 76 | O60318 | |
| TQHPGESTVVSGGSE | 556 | Q8WVS4 | |
| ASGTTVSHVSDIIGP | 181 | A6NHQ2 | |
| TEVVSCHPQGSTAGV | 151 | O60486 | |
| THPVNTTVDFGGTTS | 251 | Q8N441 | |
| RGVSVAVGTTHTPIS | 696 | Q9UGI6 | |
| STGVTGIAGHSAAVT | 5546 | Q7Z5P9 | |
| EFPGTTITSGDSHTE | 6466 | Q7Z5P9 | |
| VIPGSSGTISHTTVA | 7801 | Q7Z5P9 | |
| SGTISHTTVAPGSSV | 7806 | Q7Z5P9 | |
| HTTVAPGSSVTGTTT | 7811 | Q7Z5P9 | |
| VNSSNHGPVSTGSLT | 516 | Q13370 | |
| HQDPSQATGTTGSSV | 61 | Q96KR6 | |
| TGQVVSFGHGPSDTS | 306 | Q8IVU3 | |
| VGSEVPGTVISFVTH | 491 | Q9NUL7 | |
| TATGLGSHVEVTPHT | 1611 | P50851 | |
| SRGGPTATSVTQGTH | 1721 | P98088 | |
| GGPTATSVTQGTHTT | 2096 | P98088 | |
| GIPTVASDTFVSTDH | 1351 | P23471 | |
| PVVSHQETSVGALGS | 31 | Q9BSJ6 | |
| TSASSGGHVTFRPVS | 591 | Q96M63 | |
| HQTGETVTGSGTQTQ | 221 | Q9UBG3 | |
| VSSGVQTAHSNTIPT | 616 | Q7Z6E9 | |
| GTHQPGNSVSLEFST | 581 | P78509 | |
| QAVSSTGGSIVIHSP | 376 | Q6AI39 | |
| TVTHITAFDPDSTGQ | 346 | Q9HCG7 | |
| IETGQQTTTFTGHTG | 171 | P62873 | |
| NTTALIPATHNTGGS | 231 | Q6UUV9 | |
| ERHTSVQTTSSGSGP | 271 | P02751 | |
| VFSGHTLGSVISTDP | 301 | O15360 | |
| SHTEVQGSGSSRSPE | 31 | J3KSC0 | |
| DSQAGQVTTSVTHAP | 791 | Q14767 | |
| PHASESNGGSILTVS | 196 | Q9HBG7 | |
| EAHGASISGTPEATT | 111 | Q7Z2K8 | |
| STVGPGGQIVHTETT | 441 | Q9C0E4 | |
| APVTVHGTLTESSCG | 1186 | Q8WYK1 | |
| TVPLGHTGTATTAAA | 276 | Q8WZA9 | |
| SGFPQNLHVTGLTTS | 916 | P10586 | |
| SVTPVSHQSVSPGGT | 531 | Q12889 | |
| SSTQGVTNHAPLSGE | 476 | Q9BXB4 | |
| SAGAVVAHPTSGTIS | 21 | O14832 | |
| NSVVTVASSGAGIHP | 416 | Q8N328 | |
| STGFSIIHPTSSEGQ | 6 | P56715 | |
| TGTTVPESIHSFIGD | 2471 | P42345 | |
| GATTTTTAVAPAGGH | 16 | Q9NXI6 | |
| PVSVHIDTSSEGSSQ | 366 | Q6P4F7 | |
| HGSGSPGSQEITQLT | 481 | Q9P270 | |
| SQTFHGAPLTVATTG | 851 | P0DJD1 | |
| TFVSLVPTSAHTGDG | 816 | O60841 | |
| GTERPSSVSSVHSEG | 2346 | O75376 | |
| STSQPASILGGSHSE | 221 | Q13485 | |
| STGVSVEPSHFTKTG | 716 | Q8IVL1 | |
| SIDISLSSGGVPSHN | 1436 | Q8IVL1 | |
| KTSEGSSTTVGFHNP | 11 | A0A1B0GU33 | |
| GSDPTVVSITGSHVN | 676 | Q9C0A6 | |
| GPSTQVTAGSNHTAV | 991 | O75592 | |
| SPTAGTAATAEHVVQ | 516 | O75626 | |
| SLQTSDHGTVQPGET | 631 | P49221 | |
| GSGSHAAAVSVQTTP | 911 | Q9NRA8 | |
| SHTSDSDVPSGVTEV | 391 | P10909 | |
| VVGTTFHGTGSAVAS | 791 | O94967 | |
| SHAPSSSDVGVSVIV | 51 | Q9HCE3 | |
| STSTLQSPVGAGTHT | 701 | Q9HCE3 | |
| GTVDSGHETSIIPNS | 1481 | Q8IZQ1 | |
| VPASSGTVVSSIHNV | 1821 | Q8IZQ1 | |
| TSTVLITSPEGTSGH | 146 | Q6UXN2 | |
| SIQATTAAGSGHPTS | 26 | P29401 | |
| GKTHTDPTSTRTVQG | 1711 | Q8IWN7 | |
| EHVPVFGSTSGSVRS | 1736 | P12270 | |
| SGSPTHTATSVLGNT | 1781 | Q92545 | |
| TITVIPTHISTGSNG | 366 | Q9UKY1 | |
| AGSVETGVTQSPTHL | 16 | A0A0C4DH59 | |
| HVVSITTSGPGTGDS | 161 | Q9Y6X8 | |
| TGDPITVIEGSSSFH | 401 | Q13470 | |
| PQTTGTITVNGYHTT | 651 | Q96Q05 | |
| STGQGNTEVVHTGTL | 126 | Q9NV72 | |
| STGTVPGHIPSTVQA | 686 | Q9H4A3 | |
| GIPTSSLTQVVHSAG | 1241 | Q9H4A3 | |
| VTSVTNGAHPEATSE | 91 | Q9Y3C0 | |
| GVSTSIGPHSIDDSN | 1796 | Q5VUA4 | |
| TGTPGTTAVSSNRDH | 166 | Q8N7P7 | |
| TTSTEEPRGTHSQGQ | 2091 | Q5THJ4 | |
| GVSQESTASHSIPGS | 331 | Q9UKN1 | |
| TSPGLQGESTAFQTH | 1126 | Q9UKN1 | |
| GLQGESTTFQTHPAS | 2686 | Q9UKN1 | |
| GEESTTSRSQPGSTH | 2826 | Q9UKN1 | |
| ESTTVHSSPGATGTA | 3191 | Q9UKN1 | |
| HTTLSPAGSTTRQGE | 3371 | Q9UKN1 | |
| TSPGLQGESTAFQTH | 3766 | Q9UKN1 | |
| HSATTVFGANTPIVS | 1116 | Q9NZM1 |